Serum and tissue expression of transforming growth factor beta 1 in psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 4, 2009, Pages 406-409

  Zaher, H ^a   Shaker, O G ^a   El Komy, M H M ^a   El Tawdi, A ^a   Fawzi, M ^a   Kadry, D ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Keratinocyte; PASI; Psoriasis; Transforming growth factor beta1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS;

ADULT; BIOPSY; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 62149138722     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.03064.x     Document Type: Article

References (18)

1. Kapp A. The role of cytokines in the psoriatic inflammation. J Dermatol Sci 1993 5 : 133 142.
2. Krueger JG, Krane JF, Carter DM, Gottlieb AB. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 1990 94 (6 Suppl 135S 140S.
3. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000 342 : 1350 1358.
4. Powell TJ, Ben Bassat H, Klein BY et al. Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors. Br J Dermatol 1999 141 : 802 810.
5. Cai JP, Falanga V, Taylor JR, Chin YH. Transforming growth factor-beta receptor binding and function are decreased in psoriatic dermal endothelium. J Invest Dermatol 1996 106 : 225 231.
6. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000 117 : 1162 1172.
7. Oyama N, Iwatsuki K, Satoh M, Akiba H, Kaneko F. Dermal fibroblasts are one of the therapeutic targets for topical application of 1alpha,25- dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction. Br J Dermatol 2000 143 : 1140 1148.
8. Leivo T, Leivo I, Kariniemi AL, Keski-Oja J, Virtanen I. Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis. Br J Dermatol 1998 138 : 57 62.
9. Flisiak I, Chodynicka B, Porebski P, Flisiak R. Association between psoriasis severity and transforming growth factor beta (1) and beta (2) in plasma and scales from psoriatic lesions. Cytokine 2002 19 : 121 125.
10. Nockowski P, Szepietowski JC, Ziarkiewicz M, Baran E. Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris. Acta Dermatovenerol Croat 2004 12 : 2 6.
11. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 835.
12. Ludwig RJ, Herzog C, Rostock A et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007 156 : 271 276.
13. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000 103 : 295 309.
14. Kane CJ, Knapp AM, Mansbridge JN, Hanawalt PC. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol 1990 144 : 144 150.
15. Wataya-Kaneda M, Hashimoto K, Kato M, Miyazono K, Yoshikawa K. Differential localization of TGF-beta-precursor isotypes in psoriatic human skin. J Dermatol Sci 1996 11 : 183 188.
16. Doi H, Shibata MA, Kiyokane K, Otsuki Y. Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris. J Dermatol Sci 2003 33 : 7 16.
17. Aly R, Maibach HE, Mandel A. Bacterial flora in psoriasis. Br J Dermatol 1976 95 : 603 606.
18. Li AG, Wang D, Feng XH, Wang XJ. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J 2004 23 : 1770 1781.